InflaRx (IFRX)
(Real Time Quote from BATS)
$1.42 USD
+0.09 (6.77%)
Updated Apr 29, 2024 01:37 PM ET
4-Sell of 5 4
F Value F Growth B Momentum F VGM
Balance Sheet
Fiscal Year End for InflaRx NV falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 98 | 86 | 99 | 93 | 129 |
Receivables | 4 | 2 | 2 | 2 | 0 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 12 | 0 | 0 | 0 | 0 |
Other Current Assets | 4 | 15 | 13 | 4 | 4 |
Total Current Assets | 118 | 103 | 113 | 99 | 133 |
Net Property & Equipment | 0 | 0 | 0 | 0 | 2 |
Investments & Advances | 10 | 3 | 32 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 1 |
Deposits & Other Assets | 0 | 0 | 0 | 0 | 1 |
Total Assets | 130 | 108 | 148 | 101 | 136 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 13 | 5 | 10 | 9 | 14 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 0 | 0 | 0 | 0 | 0 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 5 | 8 | 12 | 2 | 1 |
Total Current Liabilities | 18 | 14 | 22 | 12 | 16 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 19 | 15 | 23 | 12 | 16 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 8 | 6 | 6 | 4 | 4 |
Capital Surplus | 362 | 298 | 332 | 252 | 236 |
Retained Earnings | -310 | -257 | -253 | -192 | -150 |
Other Equity | 51 | 46 | 40 | 26 | 31 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 111 | 93 | 125 | 89 | 120 |
Total Liabilities & Shareholder's Equity | 130 | 108 | 148 | 101 | 136 |
Total Common Equity | 111 | 93 | 125 | 89 | 120 |
Shares Outstanding | 58.80 | 44.70 | 44.20 | 28.20 | 25.90 |
Book Value Per Share | 1.89 | 2.08 | 2.82 | 3.15 | 4.63 |
Fiscal Year End for InflaRx NV falls in the month of December.
All items in Millions except Per Share data.
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 98 | 125 | 112 | 73 |
Receivables | NA | 4 | 4 | 3 | 2 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 12 | 2 | 1 | 0 |
Other Current Assets | NA | 4 | 8 | 7 | 6 |
Total Current Assets | NA | 118 | 139 | 122 | 82 |
Net Property & Equipment | NA | 0 | 0 | 0 | 0 |
Investments & Advances | NA | 10 | 0 | 21 | 9 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 0 | 0 | 0 | 0 |
Total Assets | NA | 130 | 141 | 145 | 93 |
Liabilities & Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 13 | 7 | 6 | 5 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 0 | 0 | 0 | 0 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 5 | 5 | 2 | 2 |
Total Current Liabilities | NA | 18 | 12 | 8 | 7 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 19 | 13 | 9 | 8 |
Shareholders Equity | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 8 | 8 | 8 | 6 |
Capital Surplus | NA | 362 | 364 | 364 | 303 |
Retained Earnings | NA | -310 | -294 | -287 | -273 |
Other Equity | NA | 51 | 51 | 50 | 48 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 111 | 128 | 136 | 84 |
Total Liabilities & Shareholder's Equity | NA | 130 | 141 | 145 | 93 |
Total Common Equity | 0 | 111 | 128 | 136 | 84 |
Shares Outstanding | 58.80 | 58.80 | 44.70 | 44.70 | 44.70 |
Book Value Per Share | 0.00 | 1.89 | 2.87 | 3.04 | 1.89 |